Security key
126650100
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 7,456,493
- Total 13F value
- $770,930,370
- Share change
- +1,433,866
- SEC-reported price per share
- $103.45
- Number of holders
- 143
- Value change
- +$150,970,225
- Number of buys
- 73
- Number of sells
- 50
- Shares outstanding
- 1,272,949,774
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
143
Top holders
10
CVS full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
CVS HEALTH Corp SEC filings
CVS HEALTH Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 126650100
Recent filing periods:
Ownership snapshot
Top reported holders of CVS - CVS HEALTH Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
20 May 2026
13F
13D/G
3/4/5
Lead comparable stake: 8.3%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 8.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
8.3%
VANGUARD CAPITAL MANAGEMENT LLC
7.5%
Capital World Investors
5.5%
Jeffrey R. Balser
0%
Guy P. Sansone
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
8.3%
from 13D/G
|
$9,043,563,867
125,919,853 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.5%
|
$6,865,886,281
95,598,528 shares
|
$0 | 31 Mar 2026 |
| Capital World Investors |
13F
13D/G
Company
|
5.5%
from 13D/G
|
$5,547,533,163
77,248,642 shares
|
— | 31 Mar 2026 |
| Jeffrey R. Balser |
3/4/5
Director
|
0%
|
$1,128,794
15,717 shares
|
— | 14 May 2026 |
| Guy P. Sansone |
3/4/5
Director
|
0%
|
$1,084,938
15,106 shares
|
— | 14 May 2026 |
| J. Scott Kirby |
3/4/5
Director
|
0%
|
$1,036,649
14,434 shares
|
— | 14 May 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
143
Shares
7,456,493
Rows available
143
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
1,858
Q2 2026 holders
143
Holder diff
-1,715
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend